Kostadinov Ilia D, Delev Delian P, Kostadinova Ivanka I
Department of Pharmacology and Clinical Pharmacology, Medical University, Plovdiv, Bulgaria.
Folia Med (Plovdiv). 2012 Oct-Dec;54(4):69-77. doi: 10.2478/v10153-012-0008-2.
Tricyclic antidepressants are used in the treatment of various pain syndromes. The antidepressant clomipramine inhibits predominantly the reuptake of serotonin in the central nervous system. The mechanism of its analgesic effect is not fully understood. The AIM of the present study was to find experimentally any dose-effect dependence in the analgesic effect of clomipramine and the involvement of the 5-HT2 and 5-HT3 receptors in the mechanism of this effect.
Fifty male Wistar rats were used in the study allocated to five groups (10 animals each): a saline treated control group, one positive control group treated with metamizole and three experimental groups treated with intraperitoneally administered clomipramine in doses of 5, 10 and 20 mg/kg bw, respectively. To study the role of 5-HT2 and 5-HT3 receptors in this effect we used another five groups (10 animals each): control, positive control and three experimental groups treated with clomipramine only, clomipramine and granisetrone and clomipramine and cyproheptadine, respectively. Three nociceptive tests were used: the hot plate test, analgesimeter and the acetic acid-induced writhing test. To gauge the antinociceptive action we used the increased latency in the hot plate test expressed as maximum possible effect % (%MPE), the increase in paw pressure to withdraw the hind paw in analgesimeter and decrease in the number of spinal cord writhes in the acetic acid test.
Clomipramine in a dose of 20 mg/kg bw significantly increased the %MPE in hot plate test and the pressure to withdraw the hind paw in the analgesimeter when compared with the control. In the acetic acid test clomipramine decreased non-significantly the number of writhes compared with the controls. Granisetrone reduced non-significantly the antinociceptive effect of clomipramine in all tests. Cyproheptadine potentiated the analgesic effect of clomipramine in acetic acid test and decreased it significantly in the hot plate test. In analgesimeter cyproheptadine decreased significantly the paw pressure to withdraw the tested hind paw at 1 hour and non-significantly at 2 hours.
Clomipramine in the dose of 20 mg/kg bw has a pronounced antinociceptive affect towards thermal and mechanical pain stimulation. The 5-HT2 and 5-HT3 receptor subtypes are very likely involved in the mechanism of this effect.
三环类抗抑郁药用于治疗各种疼痛综合征。抗抑郁药氯米帕明主要抑制中枢神经系统中5-羟色胺的再摄取。其镇痛作用机制尚未完全明确。本研究的目的是通过实验找出氯米帕明镇痛作用的剂量效应依赖性以及5-HT2和5-HT3受体在该作用机制中的参与情况。
本研究使用了50只雄性Wistar大鼠,分为五组(每组10只):一个生理盐水处理的对照组、一个用安乃近处理的阳性对照组和三个分别腹腔注射5、10和20mg/kg体重氯米帕明的实验组。为研究5-HT2和5-HT3受体在该作用中的作用,我们又使用了另外五组(每组10只):对照组、阳性对照组和三个分别仅用氯米帕明、氯米帕明和格拉司琼以及氯米帕明和赛庚啶处理的实验组。使用了三种伤害感受性测试:热板试验、痛觉计和乙酸诱导扭体试验。为评估镇痛作用,我们在热板试验中使用潜伏期增加表示为最大可能效应百分比(%MPE),在痛觉计中使用后爪撤回时爪压力的增加,以及在乙酸试验中使用脊髓扭体次数的减少。
与对照组相比,20mg/kg体重剂量的氯米帕明显着增加了热板试验中的%MPE以及痛觉计中后爪撤回的压力。在乙酸试验中,与对照组相比,氯米帕明使扭体次数减少但不显著。格拉司琼在所有试验中均未显著降低氯米帕明的镇痛作用。赛庚啶在乙酸试验中增强了氯米帕明的镇痛作用,而在热板试验中则显著降低了该作用。在痛觉计中,赛庚啶在1小时时显著降低了测试后爪撤回的爪压力,在2小时时降低但不显著。
20mg/kg体重剂量的氯米帕明对热和机械性疼痛刺激具有明显的镇痛作用。5-HT2和5-HT3受体亚型很可能参与了该作用机制。